MYO
Price:
$4.72
Market Cap:
$142.76M
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration,...[Read more]
Industry
Medical - Devices
IPO Date
2017-06-12
Stock Exchange
AMEX
Ticker
MYO
According to Myomo, Inc.’s latest financial reports and current stock price. The company's current ROE is -86.30%. This represents a change of 308.29% compared to the average of -21.14% of the last 4 quarters.
The mean historical ROE of Myomo, Inc. over the last ten years is -141.08%. The current -86.30% ROE has changed -38.83% with respect to the historical average. Over the past ten years (40 quarters), MYO's ROE was at its highest in in the September 2015 quarter at 81.69%. The ROE was at its lowest in in the June 2017 quarter at -188.19%.
Average
-141.08%
Median
-100.65%
Minimum
-582.61%
Maximum
334.95%
Discovering the peaks and valleys of Myomo, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 262.89%
Maximum Annual ROE = 334.95%
Minimum Annual Increase = -571.10%
Minimum Annual ROE = -582.61%
Year | ROE | Change |
---|---|---|
2023 | -90.64% | -46.24% |
2022 | -168.59% | 150.45% |
2021 | -67.31% | -35.33% |
2020 | -104.09% | -82.13% |
2019 | -582.61% | 262.89% |
2018 | -160.55% | 65.17% |
2017 | -97.20% | -571.10% |
2016 | 20.63% | -93.84% |
2015 | 334.95% | -167.61% |
The current ROE of Myomo, Inc. (MYO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-108.84%
5-year avg
-202.65%
10-year avg
-141.08%
Myomo, Inc.’s ROE is greater than Sintx Technologies, Inc. (-140.68%), greater than ReShape Lifesciences Inc. (-208.37%), greater than Bone Biologics Corporation (-154.16%), greater than Ra Medical Systems, Inc. (-15.34%), greater than Tivic Health Systems, Inc. (-172.08%), greater than Bluejay Diagnostics, Inc. (-155.68%), greater than Vivos Therapeutics, Inc. (-652.32%), greater than Rapid Micro Biosystems, Inc. (-48.05%), greater than Talis Biomedical Corporation (-79.73%), greater than Nuwellis, Inc. (-26908.26%), greater than Heart Test Laboratories, Inc. (-144.10%), greater than Nexalin Technology, Inc. (-187.62%), greater than INVO Bioscience, Inc. (-1073.76%), greater than Motus GI Holdings, Inc. (-1832.08%), greater than IRIDEX Corporation (-192.95%), greater than Sight Sciences, Inc. (-47.28%), greater than STRATA Skin Sciences, Inc. (-69.56%), less than Aziyo Biologics, Inc. (196.38%), greater than enVVeno Medical Corporation (-48.73%),
Company | ROE | Market cap |
---|---|---|
-140.68% | $1.62M | |
-208.37% | $2.85M | |
-154.16% | $2.47M | |
-15.34% | $3.84M | |
-172.08% | $2.05M | |
-155.68% | $2.80M | |
-652.32% | $14.87M | |
-48.05% | $50.64M | |
-79.73% | $3.21M | |
-26908.26% | $3.70M | |
-144.10% | $2.47M | |
-187.62% | $41.50M | |
-1073.76% | $3.25M | |
-1832.08% | $2.56K | |
-192.95% | $31.44M | |
-47.28% | $202.00M | |
-69.56% | $13.96M | |
196.38% | $24.21M | |
-48.73% | $59.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Myomo, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Myomo, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Myomo, Inc.'s ROE?
How is the ROE calculated for Myomo, Inc. (MYO)?
What is the highest ROE for Myomo, Inc. (MYO)?
What is the 3-year average ROE for Myomo, Inc. (MYO)?
What is the 5-year average ROE for Myomo, Inc. (MYO)?
How does the current ROE for Myomo, Inc. (MYO) compare to its historical average?